Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :i

    
• • ·Editorial Board

    Page :iii

    
• • ·Information for Readers

    Page :iv

    

• Trial Designs

  • ·Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial

    Page :1-11

    Renato D. Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, Ariane Vieira Scarlatelli Macedo, Eduardo Ramacciotti, Lucas Petri Damini, Bruna Bronhara, Alexandre B. Cavalcanti, Regis G. Rosa, Luciano C.P. Azevedo, Viviane C. Veiga, Flávia R Machado, Luiz Eduardo Ritt, Priscilla de Aquino Martins, John H. Alexander, Alvaro Avezum, Otavio Berwanger, Coalition COVID-19 Brazil IV Investigators

    Résumé Résumé Plan Plan  
  • ·Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study

    Page :16-26

    Steven A. Lubitz, Anthony Z. Faranesh, Steven J. Atlas, David D. McManus, Daniel E. Singer, Sherry Pagoto, Alexandros Pantelopoulos, Andrea S. Foulkes

    Résumé Résumé Plan Plan  
  • ·Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial

    Page :33-44

    Christian Zanchin, Konstantinos C. Koskinas, Yasushi Ueki, Sylvain Losdat, Jonas D. Häner, Sarah Bär, Tatsuhiko Otsuka, Andrea Inderkum, Maria Radu Juul Jensen, Jacob Lonborg, Gregor Fahrni, Anna S. Ondracek, Joost Daemen, Robert-Jan van Geuns, Juan F. Iglesias, Christian M. Matter, David Spirk, Peter Juni, Francois Mach, Dik Heg, Thomas Engstrom, Irene Lang, Stephan Windecker, Lorenz Räber

    Résumé Résumé Plan Plan   
  • ·Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial

    Page :45-58

    Xiulin Shi, Jiang He, Mingzhu Lin, Changqin Liu, Bing Yan, Haiqu Song, Caihong Wang, Fangsen Xiao, Peiying Huang, Liying Wang, Zhibin Li, Yinxiang Huang, Mulin Zhang, Chung-Shiuan Chen, Katherine Obst, Weihua Li, Shuyu Yang, Guanhua Yao, Xuejun Li

    Résumé Résumé Plan Plan  

• Review Articles

  • ·Financial burden, distress, and toxicity in cardiovascular disease

    Page :75-84

    Samuel D. Slavin, Rohan Khera, S. Yousuf Zafar, Khurram Nasir, Haider J. Warraich

    Résumé Résumé Plan Plan   

• Clinical Investigations

  • ·Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention

    Page :59-65

    Charan Yerasi, Brian C. Case, Chava Chezar-Azerrad, Brian J. Forrestal, Giorgio A. Medranda, Corey Shea, Cheng Zhang, Itsik Ben-Dor, Lowell F. Satler, Nelson L. Bernardo, Hayder Hashim, Hector M. Garcia-Garcia, Ron Waksman

    Résumé Résumé Plan Plan  
  • ·Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella

    Page :66-74

    Hemindermeet Singh, Rajendra H. Mehta, William O'Neill, Navin K. Kapur, Thomas Lalonde, Magnus Ohman, Ioana Ghiu, Yen Chen-Hsing, Karey Dutcheshen, Theodore Schreiber, Howard Rosman, Amir Kaki

    Résumé Résumé Plan Plan  
  • ·Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction

    Page :89-99

    Jasmine Melissa Madsen, Mia Ravn Jacobsen, Muhammad Sabbah, Divan Gabriel Topal, Reza Jabbari, Charlotte Glinge, Lars Køber, Christian Torp-Pedersen, Frants Pedersen, Rikke Sørensen, Lene Holmvang, Thomas Engstrøm, Jacob Thomsen Lønborg

    Résumé Résumé Plan Plan   
  • ·Individuals aged 1-64 years with documented congenital heart defects at healthcare encounters, five U.S. surveillance sites, 2011-2013

    Page :100-108

    M. Jill Glidewell, Sherry L. Farr, Wendy M. Book, Lorenzo Botto, Jennifer S. Li, Aida S. Soim, Karrie F. Downing, Tiffany Riehle-Colarusso, Alfred A D'Ottavio, Marcia L. Feldkamp, Amber D. Khanna, Cheryl L. Raskind-Hood, Kristin M. Sommerhalter, Tessa L Crume

    Résumé Résumé Plan Plan   

• Research Letters

  • ·Validity of different dose reduction criteria for apixaban

    Page :12-15

    Nathaniel M. Hawkins, Lee Er, Roopinder K. Sandhu, Padma Kaul, Finlay A. McAlister, Adeera Levin, Jason G. Andrade

    Résumé Résumé Plan Plan   
  • ·Neighborhood education status drives racial disparities in clinical outcomes in PPCM

    Page :27-32

    Kelly D. Getz, Jennifer Lewey, Vicky Tam, Olga Corazon Irizarry, Lisa D. Levine, Richard Aplenc, Zolt Arany

    Résumé Résumé Plan Plan  
  • ·Electronic health record risk score provides earlier prognostication of clinical outcomes in patients admitted to the cardiac intensive care unit

    Page :85-88

    Yukiko Kunitomo, Alexander Thomas, Fouad Chouairi, Maureen E. Canavan, Ajar Kochar, Rohan Khera, Jason N. Katz, Christa Murphy, Jacob Jentzer, Tariq Ahmad, Nihar R. Desai, Joseph Brennan, P. Elliott Miller

    Résumé Résumé Plan Plan